Next, to understand the relationship between atherosclerosis, the endothelium, and BRCA2 expression, we measured BRCA2 expression levels in oxLDL‐treated ECs and observed a significantly reduced BRCA2 expression following oxLDL treatment in a dose‐ and time‐dependent manner (Figure 1b,c). This evidence concerns the gene BRCA2 and atherosclerosis.